Wolff-Parkinson-White syndrome

Jump to navigation Jump to search


Resident
Survival
Guide
Wolff-Parkinson-White syndrome

Wolff-Parkinson-White syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Wolff-Parkinson-White syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Approach

History and Symptoms

Electrocardiogram

EKG Examples

Other Diagnostic Studies

Treatment

Risk Stratification

Cardioversion

Medical Therapy

Catheter Ablation

Prophylaxis

Consensus Statement

Case Studies

Case #1

Wolff-Parkinson-White syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wolff-Parkinson-White syndrome

CDC onWolff-Parkinson-White syndrome

Wolff-Parkinson-White syndrome in the news

Blogs on Wolff-Parkinson-White syndrome

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Wolff-Parkinson-White syndrome

For patient information, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]; Alonso Alvarado, M.D.

Synonyms and keywords: WPW syndrome, WPW pattern

Overview

Historical Perspective

Classification

EKG Classification | WPW Variants

Pathophysiology

Differentiating Wolff-Parkinson-White syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Approach | History and Symptoms | Electrocardiogram | EKG Examples | Other Diagnostic Studies

Treatment

Risk Stratification | Medical Therapy | Drug Prophylaxis | Management Algorithm

Recommendations for Management of Asymptomatic Patients With Asymptomatic pre-excitation

The class of Recommendation(COR) Recommendations
1 In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over

manifest pathway during exercise testing in sinus rhythm or intermittent loss of-excitation during ECG or ambulatory monitoring is useful to identify patients at low risk of rapid conduction over the pathway

2a An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for

arrhythmic events

2a Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-

excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF

2a Catheter ablation of the accessory pathway is reasonable in asymptomatic patients if the presence of

pre-excitation precludes specific employment(such as with pilots)

2a Observation,without further evaluation or treatment,is reasonable in asymptomatic patients

with pre-excitation

Related Chapters


Template:WikiDoc Sources